secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edgewise Therapeutics, Inc. (EWTX)
CIK:        0001710072
Form:       8-K
Filed at:   2023-06-12T23:59:59+00:00
Accession:  0001104659-23-070064
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Edgewise Therapeutics shareholders elect three Class II directors, ratify KPMG as auditor at 2023 annual meeting
--------------------------------------------------------------------------------

- Laura Brege reelected with 47,325,534 votes for, 11,602,125 withheld; broker non-votes 1,064,399.
- Badreddin Edris reelected with 45,321,337 for, 13,606,322 withheld; broker non-votes 1,064,399.
- Jonathan Root reelected with 45,595,269 for, 13,332,390 withheld; broker non-votes 1,064,399.
- Ratification of KPMG as independent auditor passed with 59,989,284 for, 2,555 against, 219 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710072/000110465923070064/0001104659-23-070064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710072/000110465923070064/tm2318406d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-070064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer